You are here

Our science / Clinical Trials / Find a Trial / NCT00705042

Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects

Back to Search Print Save as PDF Bookmark Trial

NCT00705042

Last updated on February 18, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Guangzhou, Guangdong, 510006 China
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Subjects
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-45 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Healthy male Chinese subjects, ages 18 to 45. BMI in the range of 18 to 30 kg/m2 and weight
greater than or equal to 50 kg.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Active tuberculosis (TB) or history of TB. Serious infection (associated with
hospitalization and/or antibiotics) within 1 month before study drug administration.

History of protein drug hypersensitivity.

NCT00705042
Pfizer
Completed
Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy Subjects
A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects
NCT02391623
All Genders
18+
Years
Brussels,
Healthy Subjects
A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.
NCT01250756
All Genders
0+
Years
Multiple Sites
Healthy Subjects
Study Evaluating Single Doses of GAP-134
NCT00820521
All Genders
Healthy Subjects
Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate
NCT00369304
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now